Background and Purpose: Practice guidelines recommend that most patients receive
moderate-or high-potency statins after ischemic stroke or transient ischemic attack (TIA) of …

Background: Statin treatment is effective at preventing adverse vascular events after
ischemic stroke (IS). However, many patients fail to use statins after IS. We studied the …

Background In‐hospital discontinuation of statins has been linked to poorer early stroke
outcomes, but the consequences of postdischarge discontinuation or dose reduction of …

Background: The benefit of statins on stroke incidence is well known. However, data on the
relationship between pre-and post-stroke statin use, recurrence, and survival outcomes are …

Background Published guidelines recommend high‐intensity statins following an ischemic
stroke or transient ischemic attack (TIA). The authors examined the potential for disparate …

Background and Purpose—The majority of patients with previous ischemic stroke are
expected to benefit significantly from long-term statin therapy. However, discontinuation of …

Background—In patients with ischemic stroke, data on the real-world effectiveness of statin
therapy for clinical and patient-centered outcomes are needed to better inform shared …

Background Statins are essential for secondary prevention after ischaemic stroke (IS).
However, statin intensity recommendations differ, and there is a concern about intracerebral …

Background and Purpose—Statins reduce the risk of stroke in at-risk populations and may
improve outcomes in patients taking statins before an ischemic stroke (IS). Our objectives …

Background Statins reportedly improve clinical outcomes for ischemic stroke patients.
However, it is unclear whether the contribution of statin treatment varies depending on the …